Entero Therapeutics Announces Proposed Reverse Merger with Journey Therapeutics: A Clinical Stage First-in-Class Next Generation ADC Rivaling Nano-immunoconjugates Biopharmaceutical

Entero Therapeutics, Inc. Announcement of Proposed Merger with Journey Therapeutics, Inc. Overview Entero Therapeutics, Inc. (Nasdaq: ENTO) has announced a binding term sheet for a reverse merger transaction with Journey Therapeutics, Inc. The Proposed Merger will result in Journey shareholders acquiring 99% of Entero’s equity. The combined company, operating under the name Journey Therapeutics, Inc.,…

Read More

ICF International Q4 2024 Earnings Call Transcript: Insights from ICFI’s Quarterly Financial Update

ICF International, Inc. (NASDAQ: ICFI ) Q4 2024 Earnings Call Transcript On February 27, 2025, at 4:30 PM ET, ICF International, Inc. (ICFI) held its Q4 2024 earnings call. The call was led by Lynn Morgen, Investor Relations, Advisiry Partners, with John Wasson, Chair and Chief Executive Officer, and Barry Broadus, Chief Financial Officer, representing…

Read More

Linkers Industries Limited Receives Surprising Letter from Nasdaq: Time to Raise the Minimum Bid Price!

Linkers Industries Receives Nasdaq Minimum Bid Price Deficiency Notice: What Does It Mean for Investors and the Industry? New York, March 13, 2025 – Linkers Industries Limited (Nasdaq: LNKS), a leading manufacturer and supplier of wire/cable harnesses based in Malaysia, recently disclosed that it had received a Nasdaq Minimum Bid Price Deficiency Letter. This letter,…

Read More

“Act Now: APLT Shareholders Take Action with BFA Law Before February 18 Deadline”

Securities Lawsuit Filed Against Applied Therapeutics, Inc. In a recent announcement, leading securities law firm Bleichmar Fonti & Auld LLP revealed that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain senior executives of the company for potential violations of federal securities laws. This development has caught the attention of investors…

Read More

“Breaking News: The BC Bud Co. Secures Larger Funding and Completes 2nd Tranche Closing”

The BC Bud Corporation Expands Private Placement Offering Vancouver, British Columbia–(Newsfile Corp. – January 24, 2025) The BC Bud Corporation (CSE: BCBC) (OTC Pink: BCBCF) (FSE: W04), commonly known as The BC Bud Co, has announced an increase in the size of its non-brokered private placement The BC Bud Corporation, a leading cannabis company based…

Read More